IRIS
CHITI, ARTURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.356
EU - Europa 2.078
AS - Asia 2.030
AF - Africa 362
SA - Sud America 232
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 6
Totale 15.075
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.181
SG - Singapore 1.031
CN - Cina 652
FI - Finlandia 545
IE - Irlanda 399
NG - Nigeria 349
DE - Germania 253
IT - Italia 212
BR - Brasile 204
FR - Francia 164
CA - Canada 162
NL - Olanda 122
SE - Svezia 120
IN - India 110
GB - Regno Unito 88
TR - Turchia 81
BE - Belgio 52
IL - Israele 52
RU - Federazione Russa 47
HK - Hong Kong 31
IR - Iran 13
AT - Austria 12
CZ - Repubblica Ceca 10
BD - Bangladesh 8
CL - Cile 8
EU - Europa 8
JP - Giappone 8
AR - Argentina 7
UA - Ucraina 7
ES - Italia 6
IQ - Iraq 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
EE - Estonia 5
KG - Kirghizistan 5
MX - Messico 5
PA - Panama 5
AU - Australia 4
CH - Svizzera 4
EC - Ecuador 4
KE - Kenya 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EG - Egitto 3
MA - Marocco 3
MT - Malta 3
PH - Filippine 3
PL - Polonia 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
GR - Grecia 2
HR - Croazia 2
JM - Giamaica 2
LT - Lituania 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
TN - Tunisia 2
AM - Armenia 1
BG - Bulgaria 1
CO - Colombia 1
DK - Danimarca 1
GT - Guatemala 1
HU - Ungheria 1
ID - Indonesia 1
IS - Islanda 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 15.075
Salva come PNG Salva come JPEG
Città #
Wilmington 2.010
Chandler 1.882
San Mateo 776
Ann Arbor 609
Helsinki 545
Shanghai 529
Leawood 401
Dublin 398
Singapore 374
Boardman 354
Benin City 348
Lawrence 327
Princeton 327
Ashburn 299
Fairfield 195
New York 187
Woodbridge 181
Paris 161
Toronto 159
Amsterdam 111
Pune 95
Kocaeli 80
Milan 79
London 75
Seattle 72
San Diego 57
Brussels 51
Norwalk 49
Monmouth Junction 44
Beijing 32
Santa Clara 32
Falls Church 30
Moscow 27
Los Angeles 26
Phoenix 20
Houston 17
São Paulo 17
Redmond 15
Redwood City 14
Munich 12
Belo Horizonte 11
Cambridge 11
Council Bluffs 11
Falkenstein 11
Des Moines 10
Naples 10
Zhengzhou 10
Berlin 9
Rio de Janeiro 9
Tappahannock 9
Terracina 8
Vienna 8
Abbiategrasso 7
Andover 7
Brno 7
Florence 7
Reston 6
Augusta 5
Bishkek 5
Brasília 5
Buffalo 5
Frankfurt am Main 5
Hangzhou 5
Hanover 5
Hong Kong 5
Jacksonville 5
St Petersburg 5
Tallinn 5
Chengdu 4
Mumbai 4
Osasco 4
Porto Alegre 4
Sacramento 4
Samarate 4
San Jose 4
Valencia 4
Baghdad 3
Clearwater 3
Dhaka 3
Genoa 3
Guangzhou 3
Hebei 3
Mestre 3
Montevideo 3
Nairobi 3
Nuremberg 3
Osimo 3
Pozzuoli 3
Rogeno 3
Saint Paul 3
São Bernardo do Campo 3
Taipei 3
Tel Aviv 3
Apo 2
Arapongas 2
Avigliano 2
Bangkok 2
Bari 2
Belém 2
Bucha 2
Totale 11.320
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 115
111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer. 106
111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer 101
11Cl-choline PET/CT in imaging locally advanced prostate cancer 95
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 80
Applications of PET imaging with radiolabelled choline (C-11/F-18-choline) 79
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 78
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 78
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy 74
[F-18] FDG PET/CT features for the molecular characterization of primary breast tumors 74
A portrait of the scientist as a young woman Comments after the first EANM Young Investigators' Meeting 73
A case of metastatic axillary lymph nodes involvement from unknown primary cancer: Clinical usefulness of [Tc-99m]-sestamibi 73
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 73
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy 72
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 71
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 69
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 68
A DOUBTFUL IMAGE OF LEVEEN SHUNT PATENCY 68
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 68
Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals 67
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 67
PREDICTIVE VALUE OF EARLY PET DURING SALVAGE CHEMOTHERAPY IN RELAPSING/REFRACTORY HODGKIN'S LYMPHOMA (HL) PATIENTS 66
I-131/I-123-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging 65
Evaluation of response: is F-18-FDG PET the answer? 64
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 64
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 64
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 64
INDIUM-111-DTPA-OCTREOTIDE SCINTIGRAPHY MODULATION BY TREATMENT WITH UNLABELED SOMATOSTATIN ANALOG IN SMALL-CELL LUNG-CANCER 63
C-11-Methionine uptake in secondary brain epilepsy 63
Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy 63
F-18-DOPA PET/CT in Neuroblastoma Comparison of Conventional Imaging With CT/MR 62
Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail 61
Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: Can positron emission tomography (PET) with F-18-FDG be considered as the best method? 61
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 61
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 60
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 60
Molecular Imaging in Radiotherapy Planning for Head and Neck Tumors 60
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 60
Pancreatic cancer or chronic pancreatitis? An answer from PET/MRI image fusion 59
Radiopharmaceuticals for breast cancer imaging 59
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine 58
PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014 58
Multimodal Characterization of Supratentorial Gliomas: Relationship Among Morphological, Metabolic and Molecular features 58
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 58
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 58
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 58
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 57
Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases 57
Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer. Eur Urol 2011;59:572-83 57
Assessment of tumor response in malignant pleural mesothelioma 57
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 57
A case of atypical giant cell arteritis diagnosed by positron emission tomography (PET) 57
A risk management approach for imaging biomarker-driven clinical trials in oncology 57
EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma 57
Role of I-131-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours - Experience of the National Cancer Institute of Milan 56
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines 56
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma 56
Correlation of microvascular fractal dimension with positron emission tomography [C-11]-methionine uptake in glioblastoma multiforme: Preliminary findings 55
Standardization and quantification in PET/CT imaging: tracers beyond FDG. 55
FDG-PET as a tool to optimize residual surgery in patients with primary extragonadal germ cell tumors: preliminary results 55
Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours 55
C-11-labeled methionine and evaluation of malignant pleural mesothelioma 54
The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors | [La scintigrafia dei recettori per la somatostatina nei tumori neuroendocrini gastro-entero-pancreatici.] 54
F-18-FDG PET/CT scans for children and adolescents 54
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 54
A method to reduce acetonitrile amount in F-18-FDG synthesis 54
Prone scintimammography in patients with non-palpable breast lesions 54
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 54
EANM procedure guideline for treatment of refractory metastatic bone pain 53
Nuclear medicine procedures in lung cancer 53
Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT 53
Cardiac and Acoustic Metastases in Relapsing Melanoma 53
The Path to the Future: Education of Nuclear Medicine Therapeutic Specialists as Responsible Physicians 53
Bone lesion in a patient with transplanted liver for a metastatic carcinoid. The role of somatostatin receptor scintigraphy 53
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology 53
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 53
Prognostic significance of molecular and imaging biomarkers in primary brain tumors 53
CASE-REPORT - TECHNETIUM-99M-HEXAKIS-2-METHOXY-ISOBUTYL-ISONITRILE IMAGING OF BREAST-CANCER AND MYOCARDIAL-INFARCTION IN THE SAME PATIENT 53
Joint Practice Guidelines for Radionuclide Lymphoscintigraphy for Sentinel Node Localization in Oral/Oropharyngeal Squamous Cell Carcinoma 53
FDG PET/CT predictive role in follicular lymphoma 52
PRELIMINARY-RESULTS OF PREOPERATIVE AXILLARY RADIOIMMUNOSCINTIGRAPHY WITH IN-111 B72.3 IN BREAST-CANCER 52
New Clinical Indications for F-18/C-11-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature 52
Consensus on molecular imaging and theranostics in prostate cancer 52
[C-11] Choline PET/CT Impacts Treatment Decision Making in Patients With Prostate Cancer Referred for Radiotherapy 52
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning 52
Targeted PET/TRUS software fusion‑guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: A feasibility study and preliminary results 52
In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging 51
Exploration of Disease Markers under Translational Medicine Model 51
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 51
SEGMENTAL FDG-PET/CT IN SOLITARY PULMONARY NODULE: PRELIMINARY DATA OF THE PET ITALIAN TRIAL 51
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 51
Prognostic and predictive role of [F-18]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy 51
Pretransplantation pet as major prognostic discriminant in IGEV-treated patients with refractory/relapsed Hodgkin's lymphoma (HL) 51
Utility of gallium-67 in determining the radicality of lymph node dissections of the neck for metastatic lymph nodes with extranodal spread in patients affected by carcinoma of the head and neck 51
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 51
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 51
Axillary node metastasis detection in breast cancer with Tc-99m-sestamibi and In-111-pentetreotide 51
PET in radiotherapy planning: Particularly exquisite test or pending and experimental tool? 50
Comments on the Italian Society of Endocrinology recommendations on post-surgical thyroid ablation in differentiated thyroid cancer 50
Why New Journals? The Growth of the EJNMMI Family 50
Totale 6.056
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.590
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 0 0 0 0 0 0 20
2020/20213.889 38 50 45 17 37 1.227 544 278 734 501 38 380
2021/20221.919 161 17 62 414 37 28 73 260 161 129 486 91
2022/20235.106 748 197 462 560 456 462 10 410 947 432 344 78
2023/20242.627 220 320 583 174 63 301 150 129 51 35 240 361
2024/20251.678 90 71 28 42 62 431 195 380 379 0 0 0
Totale 15.239